BridgeBio Oncology Thera maintained at Buy by Canaccord Genuity
Canaccord Genuity maintained a Buy rating on BBOT, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.